目次

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Market Definitions
1.3. Research Methodology
1.3.1. Information Procurement
1.3.2. Information or Data Analysis
1.3.3. Market Formulation & Data Visualization
1.3.4. Data Validation & Publishing
1.4. Research Scope and Assumptions
1.4.1. List of Data Sources

Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights

Chapter 3. Oncology Companion Diagnostic Market Variables, Trends, & Scope
3.1. Market Introduction/Lineage Outlook
3.2. Market Size and Growth Prospects (USD Million)
3.3. Market Dynamics
3.3.1. Market Drivers Analysis
3.3.2. Market Restraints Analysis
3.4. Oncology Companion Diagnostic Market Analysis Tools
3.4.1. Porter’s Analysis
3.4.1.1. Bargaining power of the suppliers
3.4.1.2. Bargaining power of the buyers
3.4.1.3. Threats of substitution
3.4.1.4. Threats from new entrants
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political landscape
3.4.2.2. Economic and Social landscape
3.4.2.3. Technological landscape
3.4.2.4. Environmental landscape
3.4.2.5. Legal landscape

Chapter 4. Oncology Companion Diagnostic Market: Product & Services Estimates & Trend Analysis
4.1. Product and Services Market Share, 2024 & 2030
4.2. Segment Dashboard
4.3. Oncology Companion Diagnostic Market by Product & Services Outlook
4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
4.5. Product
4.5.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5.2. Instrument
4.5.2.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5.3. Consumables
4.5.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5.4. Software
4.5.4.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.6. Services
4.6.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Oncology Companion Diagnostic Market: Technology Estimates & Trend Analysis
5.1. Technology Market Share, 2024 & 2030
5.2. Segment Dashboard
5.3. Oncology Companion Diagnostic Market by Technology Outlook
5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
5.5. Polymerase Chain Reaction (PCR)
5.5.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.6. Next-generation Sequencing (NGS)
5.6.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.7. Immunohistochemistry (IHC)
5.7.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.8. In Situ Hybridization (ISH)/Fluorescence In Situ Hybridization (FISH)
5.8.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.9. Other Technologies
5.9.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Oncology Companion Diagnostic Market: Disease Type Estimates & Trend Analysis
6.1. Disease Type Market Share, 2024 & 2030
6.2. Segment Dashboard
6.3. Oncology Companion Diagnostic Market by Disease Type Outlook
6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
6.5. Breast Cancer
6.5.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6. Non-small Cell Lung Cancer
6.6.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.7. Colorectal Cancer
6.7.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.8. Leukemia
6.8.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.9. Melanoma
6.9.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.10. Prostate Cancer
6.10.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.11. Others
6.11.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Oncology Companion Diagnostic Market: End Use Estimates & Trend Analysis
7.1. End Use Market Share, 2024 & 2030
7.2. Segment Dashboard
7.3. Oncology Companion Diagnostic Market by Disease Type Outlook
7.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
7.5. Hospital
7.5.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6. Pathology/Diagnostic Laboratory
7.6.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.7. Academic Medical Center
7.7.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Oncology Companion Diagnostic Market: Regional Estimates & Trend Analysis
8.1. Regional Market Share Analysis, 2024 & 2030
8.2. Regional Market Dashboard
8.3. Global Regional Market Snapshot
8.4. Market Size, & Forecasts, Trend Analysis, 2018 to 2030:
8.5. North America
8.5.1. North America: SWOT Analysis
8.5.2. U.S.
8.5.2.1. Key country dynamics
8.5.2.2. Regulatory framework
8.5.2.3. Competitive scenario
8.5.2.4. U.S. market estimates and forecasts 2018 to 2030, (USD Million)
8.5.3. Canada
8.5.3.1. Key country dynamics
8.5.3.2. Regulatory framework
8.5.3.3. Competitive scenario
8.5.3.4. Canada market estimates and forecasts 2018 to 2030, (USD Million)
8.5.4. Mexico
8.5.4.1. Key country dynamics
8.5.4.2. Regulatory framework
8.5.4.3. Competitive scenario
8.5.4.4. Canada market estimates and forecasts 2018 to 2030, (USD Million)
8.6. Europe
8.6.1. Europe: SWOT Analysis
8.6.2. UK
8.6.2.1. Key country dynamics
8.6.2.2. Regulatory framework
8.6.2.3. Competitive scenario
8.6.2.4. UK market estimates and forecasts 2018 to 2030, (USD Million)
8.6.3. Germany
8.6.3.1. Key country dynamics
8.6.3.2. Regulatory framework
8.6.3.3. Competitive scenario
8.6.3.4. Germany market estimates and forecasts 2018 to 2030, (USD Million)
8.6.4. France
8.6.4.1. Key country dynamics
8.6.4.2. Regulatory framework
8.6.4.3. Competitive scenario
8.6.4.4. France market estimates and forecasts 2018 to 2030, (USD Million)
8.6.5. Italy
8.6.5.1. Key country dynamics
8.6.5.2. Regulatory framework
8.6.5.3. Competitive scenario
8.6.5.4. Italy market estimates and forecasts 2018 to 2030, (USD Million)
8.6.6. Spain
8.6.6.1. Key country dynamics
8.6.6.2. Regulatory framework
8.6.6.3. Competitive scenario
8.6.6.4. Spain market estimates and forecasts 2018 to 2030, (USD Million)
8.6.7. Norway
8.6.7.1. Key country dynamics
8.6.7.2. Regulatory framework
8.6.7.3. Competitive scenario
8.6.7.4. Norway market estimates and forecasts 2018 to 2030, (USD Million)
8.6.8. Sweden
8.6.8.1. Key country dynamics
8.6.8.2. Regulatory framework
8.6.8.3. Competitive scenario
8.6.8.4. Sweden market estimates and forecasts 2018 to 2030, (USD Million)
8.6.9. Denmark
8.6.9.1. Key country dynamics
8.6.9.2. Regulatory framework
8.6.9.3. Competitive scenario
8.6.9.4. Denmark market estimates and forecasts 2018 to 2030, (USD Million)
8.7. Asia Pacific
8.7.1. Asia Pacific: SWOT Analysis
8.7.2. Japan
8.7.2.1. Key country dynamics
8.7.2.2. Regulatory framework
8.7.2.3. Competitive scenario
8.7.2.4. Japan market estimates and forecasts 2018 to 2030, (USD Million)
8.7.3. China
8.7.3.1. Key country dynamics
8.7.3.2. Regulatory framework
8.7.3.3. Competitive scenario
8.7.3.4. China market estimates and forecasts 2018 to 2030, (USD Million)
8.7.4. India
8.7.4.1. Key country dynamics
8.7.4.2. Regulatory framework
8.7.4.3. Competitive scenario
8.7.4.4. India market estimates and forecasts 2018 to 2030, (USD Million)
8.7.5. Australia
8.7.5.1. Key country dynamics
8.7.5.2. Regulatory framework
8.7.5.3. Competitive scenario
8.7.5.4. Australia market estimates and forecasts 2018 to 2030, (USD Million)
8.7.6. South Korea
8.7.6.1. Key country dynamics
8.7.6.2. Regulatory framework
8.7.6.3. Competitive scenario
8.7.6.4. South Korea market estimates and forecasts 2018 to 2030, (USD Million)
8.7.7. Thailand
8.7.7.1. Key country dynamics
8.7.7.2. Regulatory framework
8.7.7.3. Competitive scenario
8.7.7.4. Thailand market estimates and forecasts 2018 to 2030, (USD Million)
8.8. Latin America
8.8.1. Latin America: SWOT Analysis
8.8.2. Brazil
8.8.2.1. Key country dynamics
8.8.2.2. Regulatory framework
8.8.2.3. Competitive scenario
8.8.2.4. Brazil market estimates and forecasts 2018 to 2030, (USD Million)
8.8.3. Argentina
8.8.3.1. Key country dynamics
8.8.3.2. Regulatory framework
8.8.3.3. Competitive scenario
8.8.3.4. Argentina market estimates and forecasts 2018 to 2030, (USD Million)
8.9. MEA
8.9.1. MEA: SWOT Analysis
8.9.2. South Africa
8.9.2.1. Key country dynamics
8.9.2.2. Regulatory framework
8.9.2.3. Competitive scenario
8.9.2.4. South Africa market estimates and forecasts 2018 to 2030, (USD Million)
8.9.3. Saudi Arabia
8.9.3.1. Key country dynamics
8.9.3.2. Regulatory framework
8.9.3.3. Competitive scenario
8.9.3.4. Saudi Arabia market estimates and forecasts 2018 to 2030, (USD Million)
8.9.4. UAE
8.9.4.1. Key country dynamics
8.9.4.2. Regulatory framework
8.9.4.3. Competitive scenario
8.9.4.4. UAE market estimates and forecasts 2018 to 2030, (USD Million)
8.9.5. Kuwait
8.9.5.1. Key country dynamics
8.9.5.2. Regulatory framework
8.9.5.3. Competitive scenario

Chapter 9. Competitive Landscape
9.1. Recent Developments & Impact Analysis by Key Market Participants
9.2. Company Categorization
9.3. Company Heat Map Analysis
9.4. Company Profiles
9.4.1. Agilent Technologies, Inc.
9.4.1.1. Participant’s Overview
9.4.1.2. Financial Performance
9.4.1.3. Product Benchmarking
9.4.1.4. Recent Developments/ Strategic Initiatives
9.4.2. Illumina, Inc.
9.4.2.1. Participant’s Overview
9.4.2.2. Financial Performance
9.4.2.3. Product Benchmarking
9.4.2.4. Recent Developments/ Strategic Initiatives
9.4.3. QIAGEN
9.4.3.1. Participant’s Overview
9.4.3.2. Financial Performance
9.4.3.3. Product Benchmarking
9.4.3.4. Recent Developments/ Strategic Initiatives
9.4.4. Thermo Fisher Scientific Inc.
9.4.4.1. Participant’s Overview
9.4.4.2. Financial Performance
9.4.4.3. Product Benchmarking
9.4.4.4. Recent Developments/ Strategic Initiatives
9.4.5. Foundation Medicine, Inc.
9.4.5.1. Participant’s Overview
9.4.5.2. Financial Performance
9.4.5.3. Product Benchmarking
9.4.5.4. Recent Developments/ Strategic Initiatives
9.4.6. Myriad Genetics, Inc.
9.4.6.1. Participant’s Overview
9.4.6.2. Financial Performance
9.4.6.3. Product Benchmarking
9.4.6.4. Recent Developments/ Strategic Initiatives
9.4.7. F. Hoffmann-La Roche Ltd
9.4.7.1. Financial Performance
9.4.7.2. Product Benchmarking
9.4.7.3. Recent Developments/ Strategic Initiatives
9.4.8. BIOMÉRIEUX
9.4.8.1. Participant’s Overview
9.4.8.2. Financial Performance
9.4.8.3. Product Benchmarking
9.4.8.4. Recent Developments/ Strategic Initiatives
9.4.9. Abbott
9.4.9.1. Participant’s Overview
9.4.9.2. Financial Performance
9.4.9.3. Product Benchmarking
9.4.9.4. Recent Developments/ Strategic Initiatives
9.4.10. Leica Biosystems Nussloch GmbH
9.4.10.1. Participant’s Overview
9.4.10.2. Financial Performance
9.4.10.3. Product Benchmarking
9.4.10.4. Recent Developments/ Strategic Initiatives
9.4.11. Guardant Health
9.4.11.1. Participant’s Overview
9.4.11.2. Financial Performance
9.4.11.3. Product Benchmarking
9.4.11.4. Recent Developments/ Strategic Initiatives
9.4.12. EntroGen, Inc.
9.4.12.1. Participant’s Overview
9.4.12.2. Financial Performance
9.4.12.3. Product Benchmarking
9.4.12.4. Recent Developments/ Strategic Initiatives

List of Tables
Table 1 List of abbreviation
Table 2 North America oncology companion diagnostic market, by region, 2018 - 2030 (USD Million)
Table 3 North America oncology companion diagnostic market, by product and services, 2018 - 2030 (USD Million)
Table 4 North America oncology companion diagnostic market, by technology, 2018 - 2030 (USD Million)
Table 5 North America oncology companion diagnostic market, by disease, 2018 - 2030 (USD Million)
Table 6 North America oncology companion diagnostic market, by end use, 2018 - 2030 (USD Million)
Table 7 U.S. oncology companion diagnostic market, by product and services, 2018 - 2030 (USD Million)
Table 8 U.S. oncology companion diagnostic market, by technology, 2018 - 2030 (USD Million)
Table 9 U.S. oncology companion diagnostic market, by disease, 2018 - 2030 (USD Million)
Table 10 U.S. oncology companion diagnostic market, by end use, 2018 - 2030 (USD Million)
Table 11 Canada oncology companion diagnostic market, by product and services, 2018 - 2030 (USD Million)
Table 12 Canada oncology companion diagnostic market, by technology, 2018 - 2030 (USD Million)
Table 13 Canada oncology companion diagnostic market, by disease, 2018 - 2030 (USD Million)
Table 14 Canada oncology companion diagnostic market, by end use, 2018 - 2030 (USD Million)
Table 15 Mexico oncology companion diagnostic market, by product and services, 2018 - 2030 (USD Million)
Table 16 Mexico oncology companion diagnostic market, by technology, 2018 - 2030 (USD Million)
Table 17 Mexico oncology companion diagnostic market, by disease, 2018 - 2030 (USD Million)
Table 18 Mexico oncology companion diagnostic market, by end use, 2018 - 2030 (USD Million)
Table 19 Europe oncology companion diagnostic market, by region, 2018 - 2030 (USD Million)
Table 20 Europe oncology companion diagnostic market, by product and services, 2018 - 2030 (USD Million)
Table 21 Europe oncology companion diagnostic market, by technology, 2018 - 2030 (USD Million)
Table 22 Europe oncology companion diagnostic market, by disease, 2018 - 2030 (USD Million)
Table 23 Europe oncology companion diagnostic market, by end use, 2018 - 2030 (USD Million)
Table 24 Germany oncology companion diagnostic market, by product and services, 2018 - 2030 (USD Million)
Table 25 Germany oncology companion diagnostic market, by technology, 2018 - 2030 (USD Million)
Table 26 Germany oncology companion diagnostic market, by disease, 2018 - 2030 (USD Million)
Table 27 Germany oncology companion diagnostic market, by end use, 2018 - 2030 (USD Million)
Table 28 UK oncology companion diagnostic market, by product and services, 2018 - 2030 (USD Million)
Table 29 UK oncology companion diagnostic market, by technology, 2018 - 2030 (USD Million)
Table 30 UK oncology companion diagnostic market, by disease, 2018 - 2030 (USD Million)
Table 31 UK oncology companion diagnostic market, by end use, 2018 - 2030 (USD Million)
Table 32 France oncology companion diagnostic market, by product and services, 2018 - 2030 (USD Million)
Table 33 France oncology companion diagnostic market, by technology, 2018 - 2030 (USD Million)
Table 34 France oncology companion diagnostic market, by disease, 2018 - 2030 (USD Million)
Table 35 France oncology companion diagnostic market, by end use, 2018 - 2030 (USD Million)
Table 36 Italy oncology companion diagnostic market, by product and services, 2018 - 2030 (USD Million)
Table 37 Italy oncology companion diagnostic market, by technology, 2018 - 2030 (USD Million)
Table 38 Italy oncology companion diagnostic market, by disease, 2018 - 2030 (USD Million)
Table 39 Italy oncology companion diagnostic market, by end use, 2018 - 2030 (USD Million)
Table 40 Spain oncology companion diagnostic market, by product and services, 2018 - 2030 (USD Million)
Table 41 Spain oncology companion diagnostic market, by technology, 2018 - 2030 (USD Million)
Table 42 Spain oncology companion diagnostic market, by disease, 2018 - 2030 (USD Million)
Table 43 Spain oncology companion diagnostic market, by end use, 2018 - 2030 (USD Million)
Table 44 Denmark oncology companion diagnostic market, by product and services, 2018 - 2030 (USD Million)
Table 45 Denmark oncology companion diagnostic market, by technology, 2018 - 2030 (USD Million)
Table 46 Denmark oncology companion diagnostic market, by disease, 2018 - 2030 (USD Million)
Table 47 Denmark oncology companion diagnostic market, by end use, 2018 - 2030 (USD Million)
Table 48 Sweden oncology companion diagnostic market, by product and services, 2018 - 2030 (USD Million)
Table 49 Sweden oncology companion diagnostic market, by technology, 2018 - 2030 (USD Million)
Table 50 Sweden oncology companion diagnostic market, by disease, 2018 - 2030 (USD Million)
Table 51 Sweden oncology companion diagnostic market, by end use, 2018 - 2030 (USD Million)
Table 52 Norway oncology companion diagnostic market, by product and services, 2018 - 2030 (USD Million)
Table 53 Norway oncology companion diagnostic market, by technology, 2018 - 2030 (USD Million)
Table 54 Norway oncology companion diagnostic market, by disease, 2018 - 2030 (USD Million)
Table 55 Norway oncology companion diagnostic market, by end use, 2018 - 2030 (USD Million)
Table 56 Asia Pacific oncology companion diagnostic market, by region, 2018 - 2030 (USD Million)
Table 57 Asia Pacific oncology companion diagnostic market, by product and services, 2018 - 2030 (USD Million)
Table 58 Asia Pacific oncology companion diagnostic market, by technology, 2018 - 2030 (USD Million)
Table 59 Asia Pacific oncology companion diagnostic market, by disease, 2018 - 2030 (USD Million)
Table 60 Asia Pacific oncology companion diagnostic market, by end use, 2018 - 2030 (USD Million)
Table 61 China oncology companion diagnostic market, by product and services, 2018 - 2030 (USD Million)
Table 62 China oncology companion diagnostic market, by technology, 2018 - 2030 (USD Million)
Table 63 China oncology companion diagnostic market, by disease, 2018 - 2030 (USD Million)
Table 64 China oncology companion diagnostic market, by end use, 2018 - 2030 (USD Million)
Table 65 Japan oncology companion diagnostic market, by product and services, 2018 - 2030 (USD Million)
Table 66 Japan oncology companion diagnostic market, by technology, 2018 - 2030 (USD Million)
Table 67 Japan oncology companion diagnostic market, by disease, 2018 - 2030 (USD Million)
Table 68 Japan oncology companion diagnostic market, by end use, 2018 - 2030 (USD Million)
Table 69 India oncology companion diagnostic market, by product and services, 2018 - 2030 (USD Million)
Table 70 India oncology companion diagnostic market, by technology, 2018 - 2030 (USD Million)
Table 71 India oncology companion diagnostic market, by disease, 2018 - 2030 (USD Million)
Table 72 India oncology companion diagnostic market, by end use, 2018 - 2030 (USD Million)
Table 73 South Korea oncology companion diagnostic market, by product and services, 2018 - 2030 (USD Million)
Table 74 South Korea oncology companion diagnostic market, by technology, 2018 - 2030 (USD Million)
Table 75 South Korea oncology companion diagnostic market, by disease, 2018 - 2030 (USD Million)
Table 76 South Korea oncology companion diagnostic market, by end use, 2018 - 2030 (USD Million)
Table 77 Australia oncology companion diagnostic market, by product and services, 2018 - 2030 (USD Million)
Table 78 Australia oncology companion diagnostic market, by technology, 2018 - 2030 (USD Million)
Table 79 Australia oncology companion diagnostic market, by disease, 2018 - 2030 (USD Million)
Table 80 Australia oncology companion diagnostic market, by end use, 2018 - 2030 (USD Million)
Table 81 Thailand oncology companion diagnostic market, by product and services, 2018 - 2030 (USD Million)
Table 82 Thailand oncology companion diagnostic market, by technology, 2018 - 2030 (USD Million)
Table 83 Thailand oncology companion diagnostic market, by disease, 2018 - 2030 (USD Million)
Table 84 Thailand oncology companion diagnostic market, by end use, 2018 - 2030 (USD Million)
Table 85 Latin America oncology companion diagnostic market, by product and services, 2018 - 2030 (USD Million)
Table 86 Latin America oncology companion diagnostic market, by technology, 2018 - 2030 (USD Million)
Table 87 Latin America oncology companion diagnostic market, by disease, 2018 - 2030 (USD Million)
Table 88 Latin America oncology companion diagnostic market, by end use, 2018 - 2030 (USD Million)
Table 89 Brazil oncology companion diagnostic market, by product and services, 2018 - 2030 (USD Million)
Table 90 Brazil oncology companion diagnostic market, by technology, 2018 - 2030 (USD Million)
Table 91 Brazil oncology companion diagnostic market, by disease, 2018 - 2030 (USD Million)
Table 92 Brazil oncology companion diagnostic market, by end use, 2018 - 2030 (USD Million)
Table 93 Argentina oncology companion diagnostic market, by product and services, 2018 - 2030 (USD Million)
Table 94 Argentina oncology companion diagnostic market, by technology, 2018 - 2030 (USD Million)
Table 95 Argentina oncology companion diagnostic market, by disease, 2018 - 2030 (USD Million)
Table 96 Argentina oncology companion diagnostic market, by end use, 2018 - 2030 (USD Million)
Table 97 MEA oncology companion diagnostic market, by region, 2018 - 2030 (USD Million)
Table 98 MEA oncology companion diagnostic market, by product and services, 2018 - 2030 (USD Million)
Table 99 MEA oncology companion diagnostic market, by technology, 2018 - 2030 (USD Million)
Table 100 MEA oncology companion diagnostic market, by disease, 2018 - 2030 (USD Million)
Table 101 MEA oncology companion diagnostic market, by end use, 2018 - 2030 (USD Million)
Table 102 South Africa oncology companion diagnostic market, by product and services, 2018 - 2030 (USD Million)
Table 103 South Africa oncology companion diagnostic market, by technology, 2018 - 2030 (USD Million)
Table 104 South Africa oncology companion diagnostic market, by disease, 2018 - 2030 (USD Million)
Table 105 South Africa oncology companion diagnostic market, by end use, 2018 - 2030 (USD Million)
Table 106 Saudi Arabia oncology companion diagnostic market, by product and services, 2018 - 2030 (USD Million)
Table 107 Saudi Arabia oncology companion diagnostic market, by technology, 2018 - 2030 (USD Million)
Table 108 Saudi Arabia oncology companion diagnostic market, by disease, 2018 - 2030 (USD Million)
Table 109 Saudi Arabia oncology companion diagnostic market, by end use, 2018 - 2030 (USD Million)
Table 110 UAE oncology companion diagnostic market, by product and services, 2018 - 2030 (USD Million)
Table 111 UAE oncology companion diagnostic market, by technology, 2018 - 2030 (USD Million)
Table 112 UAE oncology companion diagnostic market, by disease, 2018 - 2030 (USD Million)
Table 113 UAE oncology companion diagnostic market, by end use, 2018 - 2030 (USD Million)
Table 114 Kuwait oncology companion diagnostic market, by product and services, 2018 - 2030 (USD Million)
Table 115 Kuwait oncology companion diagnostic market, by technology, 2018 - 2030 (USD Million)
Table 116 Kuwait oncology companion diagnostic market, by disease, 2018 - 2030 (USD Million)
Table 117 Kuwait oncology companion diagnostic market, by end use, 2018 - 2030 (USD Million)

List of Figures
Fig. 1 Oncology companion diagnostic market segmentation
Fig. 2 Data analysis models
Fig. 3 Market formulation and validation
Fig. 4 Data validating & publishing
Fig. 5 Market research process
Fig. 6 Information procurement
Fig. 7 Primary research
Fig. 8 Value-chain-based sizing & forecasting
Fig. 9 QFD modelling for market share assessment
Fig. 10 Market formulation & validation
Fig. 11 Commodity flow analysis
Fig. 12 Market outlook
Fig. 13 Segment snapshot-1
Fig. 14 Segment snapshot-2
Fig. 15 Competitive landscape snapshot
Fig. 16 Market trends & outlook
Fig. 17 Porter’s five force analysis
Fig. 18 PESTEL analysis
Fig. 19 Oncology companion diagnostic market: Product & Services outlook key takeaways
Fig. 20 Oncology companion diagnostic market: Product & Services movement analysis
Fig. 21 Passive immunization market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 22 Preventive vaccines market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 23 Oncology companion diagnostic market: Technology outlook key takeaways
Fig. 24 Oncology companion diagnostic market: Technology movement analysis
Fig. 25 Monoclonal antibodies market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 26 Next-generation Sequencing (NGS) market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 27 mRNA-based vaccine market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 28 Other Technologies market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 29 Oncology companion diagnostic market: Disease Type outlook key takeaways
Fig. 30 Oncology companion diagnostic market: Disease Type movement analysis
Fig. 31 Breast Cancer market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 32 Non-small Cell Lung Cancer market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 33 Colorectal Cancer market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 34 Leukemia market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 35 Melanoma market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 36 Prostate Cancer market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 37 Others estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 38 Oncology companion diagnostic market: End Use outlook key takeaways
Fig. 39 Oncology companion diagnostic market: End Use movement analysis
Fig. 40 Hospital & retail pharmacies market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 41 Government suppliers market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 42 Academic Medical Center market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 43 Regional marketplace outlook, 2024 & 2030 (USD million)
Fig. 44 Regional marketplace: Key takeaways
Fig. 45 North America Oncology companion diagnostic market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 46 Key country dynamics
Fig. 47 U.S. Oncology companion diagnostic market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 48 Key country dynamics
Fig. 49 Canada Oncology companion diagnostic market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 50 Key country dynamics
Fig. 51 Mexico Oncology companion diagnostic market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 52 Europe Oncology companion diagnostic market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 53 Key country dynamics
Fig. 54 UK Oncology companion diagnostic market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 55 Key country dynamics
Fig. 56 Germany Oncology companion diagnostic market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 57 Key country dynamics
Fig. 58 France Oncology companion diagnostic market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 59 Key country dynamics
Fig. 60 Spain Oncology companion diagnostic market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 61 Key country dynamics
Fig. 62 Italy Oncology companion diagnostic market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 63 Key country dynamics
Fig. 64 Denmark Oncology companion diagnostic market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 65 Key country dynamics
Fig. 66 Sweden Oncology companion diagnostic market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 67 Key country dynamics
Fig. 68 Norway Oncology companion diagnostic market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 69 Asia Pacific Oncology companion diagnostic market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 70 Key country dynamics
Fig. 71 Japan Oncology companion diagnostic market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 72 Key country dynamics
Fig. 73 China Oncology companion diagnostic market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 74 Key country dynamics
Fig. 75 India Oncology companion diagnostic market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 76 Key country dynamics
Fig. 77 Australia Oncology companion diagnostic market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 78 Key country dynamics
Fig. 79 South Korea Oncology companion diagnostic market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 80 Key country dynamics
Fig. 81 Thailand Oncology companion diagnostic market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 82 Key country dynamics
Fig. 83 Market participant categorization
Fig. 84 Oncology companion diagnostic market position analysis, 2024
Fig. 85 Strategic framework